Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Sickle Cell Disease Visiting Professorship ProgramRelease Date:Education Rare Disease USA Initiatives for Healthcare Professionals to Promote Intramuscular Vaccination Methods for ChildrenRelease Date:Quality Improvement Vaccines Japan Efforts to Improve Quality of Migraine Medical CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Vaccination Systems and Environments to Promote prevention of Respiratory Infections in Older AdultsRelease Date:Quality Improvement Vaccines Japan Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary CareRelease Date:Partner: Conquer Cancer, the ASCO FoundationQuality Improvement Oncology USA The Enhancement of Management of breast cancer in French speaking Sub-Saharan African CountriesRelease Date:Partner: AMFROMQuality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo Clinical Updates and Strategies in the Treatment and Management of First-line BRAF V600E-mutant Metastatic Colorectal CancerRelease Date:Education Oncology USA Guidelines and Best Practices in the Holistic Management of Patients with Metastatic Urothelial Carcinoma (mUC)Education Oncology USA Post-COVID Conditions: Potential Diagnosis, Testing, Management, and Ongoing ResearchRelease Date:Education Vaccines USA COVID-19 Disease Burden on the Pediatric PopulationRelease Date:Education Vaccines USA Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize ManagementRelease Date:Partner: Beijing Guangda Precision Medicine Research CenterQuality Improvement Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Improving the Care of Persons Living with Metastatic Breast CancerRelease Date:Partner: Rethink Breast CancerQuality Improvement Oncology Canada Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditionsRelease Date:Education Inflammation & Immunology Canada Improving Advanced Prostate Cancer Management in Latin AmericaEducation Oncology Argentina, Brazil, Chile, Colombia, Mexico Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient CareResearch Oncology USA Addressing Knowledge Gaps in Ulcerative Colitis (UC) CareRelease Date:Education Inflammation & Immunology USA 2024 Inflammatory Bowel Disease (IBD) Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the HRRm Testing Gap in Prostate Cancer PatientsRelease Date:Quality Improvement Oncology Canada Improving the care and outcomes of residents of Canada living with metastatic NSCLCRelease Date:Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung AssociationQuality Improvement Oncology Canada Improving the Equity and Quality of Cancer Care in ColombiaRelease Date:Partner: The Colombian Association of Oncology and Hematology (ACHO)Quality Improvement Oncology Colombia Enhancing Molecular Testing for Metastatic Colorectal Cancer PatientsRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement Oncology Canada Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial InfectionsRelease Date:Education Hospital All IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)Release Date:Partner: Crohn's & Colitis FoundationQuality Improvement Inflammation & Immunology USA